Observational study / 2012
Patients diagnosed with non-celiac wheat sensitivity showed distinct clinical, serological, and histological features compared to IBS controls.
Clinical charts of subjects with an IBS-like presentation diagnosed with wheat sensitivity (WS) via double-blind placebo-controlled challenge were retrospectively reviewed alongside 100 celiac disease (CD) and 50 IBS controls. Across 276 WS patients, two groups emerged: WS alone and WS associated with multiple food hypersensitivity. Compared with IBS controls, WS patients had a higher frequency of anemia, weight loss, self-reported wheat intolerance, coexistent atopy, food allergy in infancy, positive serum assays for IgG/IgA anti-gliadin, and mucosal eosinophil infiltration. Patients with WS alone showed clinical features similar to CD patients, whereas those with multiple food sensitivity resembled allergic patients.
Shows an association, not proof of cause and effect.
- Study type
- Retrospective chart review
- Who was studied
- 276 wheat sensitivity patients, 100 celiac disease controls, and 50 IBS controls
- What was measured
- Clinical, serologic, and histological markers of wheat sensitivity
THE PAPER
Non-celiac wheat sensitivity diagnosed by double-blind placebo-controlled challenge: exploring a new clinical entity.
Carroccio A, Mansueto P, Iacono G, Soresi M, D'Alcamo A, Cavataio F, Brusca I, Florena AM, Ambrosiano G, Seidita A, Pirrone G, Rini GB. Am J Gastroenterol, 2012.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.